Himadri Speciality Chemical DuPont analysis

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
0.76×0.75×0.69×0.72×0.77×
1.12×1.12×1.01×0.96×0.80×
18.0%19.2%17.3%14.2%8.4%
0.85×0.85×1.01×1.03×1.17×
1.34×1.32×1.23×1.46×1.61×
17.6%18.2%15.0%14.8%9.8%
17.8%17.8%16.4%15.4%10.4%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HSCL₹536.25

Himadri Speciality Chemical Ltd.

· Chemicals
₹ CrorePeersPCBLGRAPHITEHEGNOCILROSSARINAVINFLUORTATACHEMDDEVPLSTIKMcap ₹27,054 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×0.770.720.690.750.76
Interest Burden (Pretax/EBIT) ×0.800.961.011.121.12
EBIT Margin %8.3514.2217.3319.1818.02
Asset Turnover ×1.171.031.010.850.85
Financial Leverage (Assets/Equity) ×1.611.461.231.321.34
ROE (5-step product, year-end total equity) %9.7814.7815.0118.2417.56
ROE (owners' profit / average owners' equity) %10.4115.4216.4217.8317.83
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.